Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

ASN-ASP-ASP-CYS-GLU-LEU-CYS-VAL-ASN-VAL-ALA-CYS-THR-GLY-CYS-LEU

Base Information Edit
  • Chemical Name:ASN-ASP-ASP-CYS-GLU-LEU-CYS-VAL-ASN-VAL-ALA-CYS-THR-GLY-CYS-LEU
  • CAS No.:154525-25-4
  • Molecular Formula:C64H102 N18 O26 S4
  • Molecular Weight:1667.86
  • Hs Code.:
  • Mol file:154525-25-4.mol
ASN-ASP-ASP-CYS-GLU-LEU-CYS-VAL-ASN-VAL-ALA-CYS-THR-GLY-CYS-LEU

Synonyms:27,28,40,41-Tetrathia-2,5,8,11,14,17,20,23,31,34,37-undecaazabicyclo[14.13.13]dotetracontane,cyclic peptide deriv.; 1: PN: WO02078683 SEQID: 1 claimed protein; Humanuroguanylin; L-Leucine, L-asparaginyl-L-a-aspartyl-L-a-aspartyl-L-cysteinyl-L-a-glutamyl-L-leucyl-L-cysteinyl-L-valyl-L-asparaginyl-L-valyl-L-alanyl-L-cysteinyl-L-threonylglycyl-L-cysteinyl-,cyclic (4®12),(7®15)-bis(disulfide)

Suppliers and Price of ASN-ASP-ASP-CYS-GLU-LEU-CYS-VAL-ASN-VAL-ALA-CYS-THR-GLY-CYS-LEU
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • Usbiological
  • Uroguanylin
  • 1mg
  • $ 531.00
  • Sigma-Aldrich
  • Uroguanylin ≥90% (HPLC)
  • 0.1 mg
  • $ 705.00
  • Sigma-Aldrich
  • Uroguanylin ≥90% (HPLC)
  • .1mg
  • $ 681.00
  • American Custom Chemicals Corporation
  • UROGUANYLIN 95.00%
  • 0.1MG
  • $ 1073.00
Total 11 raw suppliers
Chemical Property of ASN-ASP-ASP-CYS-GLU-LEU-CYS-VAL-ASN-VAL-ALA-CYS-THR-GLY-CYS-LEU Edit
Chemical Property:
  • Boiling Point:2112.5±65.0 °C(Predicted) 
  • PKA:3.61±0.21(Predicted) 
  • PSA:819.33000 
  • Density:1.48±0.1 g/cm3(Predicted) 
  • LogP:-1.25710 
  • Storage Temp.:−20°C 
Purity/Quality:

99% *data from raw suppliers

Uroguanylin *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Clinical Use Two UGN/GN agonists, linaclotide and plecanatide, have recently been approved in the United States, European Union, Japan, and other countries for treatment of irritable bowel syndrome and chronic constipation. They have also been approved in the United States for treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation, respectively.
Post RFQ for Price